Ali Rıza Akyüz1, Turhan Turan2, Musluhittin Emre Erkuş3, İsmail Gürbak4, Selim Kul2, Levent Korkmaz2, Mustafa Tarık Ağaç5, Şükrü Çelik2. 1. Department of Cardiology, Ahi Evren Cardiovascular and Thoracic Surgery Training and Research Hospital, Trabzon, Turkey. dralirizaakyuz@gmail.com. 2. Department of Cardiology, Ahi Evren Cardiovascular and Thoracic Surgery Training and Research Hospital, Trabzon, Turkey. 3. Department of Cardiology, Faculty of Medicine, Harran University, Şanlıurfa, Turkey. 4. Department of Cardiology, Osmaniye State Hospital, Osmaniye, Turkey. 5. Department of Cardiology, Faculty of Medicine, Sakarya University, Sakarya, Turkey.
Abstract
BACKGROUND: Xanthelasma palpebrarum (XP) is associated with increased risk of ischemic heart disease and myocardial infarction independent of other well-known cardiovascular risk factors. Cardio-ankle vascular index (CAVI) is a novel index of arterial stiffness and important marker of subclinical atherosclerosis. The purpose of this study was to investigate the association between XP and CAVI in asymptomatic subjects. METHODS: Consecutive 50 subjects with XP and age-gender matched 50 control subjects were enrolled. Patients with known atherosclerotic vascular disease were excluded. Arterial stiffness was assessed by CAVI and defined as abnormal if CAVI is ≥ 8. RESULTS: Subjects with XP had higher mean CAVI than control subjects (8.05 ± 1.72 vs. 6.76 ± 1.18, p < 0.001). Frequency of abnormal CAVI was higher in subjects with XP (n = 27) compared to those without XP (n = 9, 54 vs. 18 %, p < 0.001). There was a significant correlation between XP and CAVI (r = 0.42, p < 0.001). Conditional logistic regression analysis showed that XP (odds ratio OR 8.80, 95 % confidence interval CI 2.63-29.49, p < 0.001) and age (OR 1.17, 95 % CI 1.08-1.26, p < 0.001) were independent predictors for abnormal CAVI. CONCLUSION: The study suggests that XP is associated with increased arterial stiffness in asymptomatic subjects.
BACKGROUND: Xanthelasma palpebrarum (XP) is associated with increased risk of ischemic heart disease and myocardial infarction independent of other well-known cardiovascular risk factors. Cardio-ankle vascular index (CAVI) is a novel index of arterial stiffness and important marker of subclinical atherosclerosis. The purpose of this study was to investigate the association between XP and CAVI in asymptomatic subjects. METHODS: Consecutive 50 subjects with XP and age-gender matched 50 control subjects were enrolled. Patients with known atherosclerotic vascular disease were excluded. Arterial stiffness was assessed by CAVI and defined as abnormal if CAVI is ≥ 8. RESULTS: Subjects with XP had higher mean CAVI than control subjects (8.05 ± 1.72 vs. 6.76 ± 1.18, p < 0.001). Frequency of abnormal CAVI was higher in subjects with XP (n = 27) compared to those without XP (n = 9, 54 vs. 18 %, p < 0.001). There was a significant correlation between XP and CAVI (r = 0.42, p < 0.001). Conditional logistic regression analysis showed that XP (odds ratio OR 8.80, 95 % confidence interval CI 2.63-29.49, p < 0.001) and age (OR 1.17, 95 % CI 1.08-1.26, p < 0.001) were independent predictors for abnormal CAVI. CONCLUSION: The study suggests that XP is associated with increased arterial stiffness in asymptomatic subjects.
Authors: Stephane Laurent; John Cockcroft; Luc Van Bortel; Pierre Boutouyrie; Cristina Giannattasio; Daniel Hayoz; Bruno Pannier; Charalambos Vlachopoulos; Ian Wilkinson; Harry Struijker-Boudier Journal: Eur Heart J Date: 2006-09-25 Impact factor: 29.983
Authors: Akira Sekikawa; Chol Shin; J David Curb; Emma Barinas-Mitchell; Kamal Masaki; Aiman El-Saed; Todd B Seto; Rachel H Mackey; Jina Choo; Akira Fujiyoshi; Katsuyuki Miura; Daniel Edmundowicz; Lewis H Kuller; Hirotsugu Ueshima; Kim Sutton-Tyrrell Journal: Atherosclerosis Date: 2012-03-27 Impact factor: 5.162
Authors: P Segal; W Insull; L E Chambless; S Stinnett; J C LaRosa; L Weissfeld; S Halfon; P O Kwiterovitch; J A Little Journal: Circulation Date: 1986-01 Impact factor: 29.690
Authors: M T Agac; H Bektas; L Korkmaz; M Cetin; H Erkan; I Gurbak; E Hatem; S Celik Journal: J Eur Acad Dermatol Venereol Date: 2014-03-14 Impact factor: 6.166
Authors: Ali Rıza Akyüz; Mustafa Tarık Ağaç; Turhan Turan; Sinan Şahin; Selim Kul; Levent Korkmaz; Musluhittin Emre Erkuş; Hakan Erkan; Şükrü Çelik Journal: Med Princ Pract Date: 2015-10-21 Impact factor: 1.927